FUERST THOMAS RICHARD 4
4 · PHARMATHENE, INC · Filed Dec 10, 2010
Insider Transaction Report
Form 4
FUERST THOMAS RICHARD
Chief Scientific Officer
Transactions
- Award
Stock Options (right to buy)
2010-12-08+75,000→ 75,000 totalExercise: $3.55Exp: 2020-12-08→ Common Stock (75,000 underlying)
Footnotes (2)
- [F1]The options vest over a 4 year period with 25% each vesting on the first, second, third and fourth anniversaries of the grant date.
- [F2]On December 8, 2010, the date such options were granted, the closing price of the Issuer's Common Stock on the NYSE Amex was $3.55 per share.